Statin therapy in patients with chronic kidney disease: to use or not to use.

about

Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor.Role of triglyceride-rich lipoproteins in renal injury.

P2860

Q36152894-09D565E9-BC72-4E0D-9CA0-3277DE221A20 Q42223823-1FB7AF1C-55FA-48BE-B429-8BD285E45AB2

P2860

Statin therapy in patients with chronic kidney disease: to use or not to use.

Item

http://www.wikidata.org/entity/Q36558703

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Statin therapy in patients with chronic kidney disease: to use or not to use.

@ast

Statin therapy in patients with chronic kidney disease: to use or not to use.

@en

type

Item

label

Statin therapy in patients with chronic kidney disease: to use or not to use.

@ast

Statin therapy in patients with chronic kidney disease: to use or not to use.

@en

prefLabel

Statin therapy in patients with chronic kidney disease: to use or not to use.

@ast

Statin therapy in patients with chronic kidney disease: to use or not to use.

@en

P1476

Statin therapy in patients with chronic kidney disease: to use or not to use.

@en

P2093

Panzer U

http://www.w3.org/2001/XMLSchema#string

Stahl RA

http://www.w3.org/2001/XMLSchema#string

Steinmetz OM

http://www.w3.org/2001/XMLSchema#string

Wenzel UO

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Progression, remission, regression of chronic renal diseases.

Chronic renal allograft rejection: pathophysiologic considerations.

Why do we need a statin trial in hemodialysis patients?

Study of Heart and Renal Protection (SHARP).

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

Statins in solid organ transplantation: is there an immunosuppressive effect?

Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

P304

519-527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2362.2006.01668.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6894451

http://www.w3.org/2001/XMLSchema#string

P698

16893373

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy

Statin therapy in patients with chronic kidney disease: to use or not to use.

about

P2860

P2860

Statin therapy in patients with chronic kidney disease: to use or not to use.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921